1. Chance, M. L. (1981). The six diseases of WHO: leishmaniasis. British Medical Journal, 283, 1245–7.
2. Antimonials: large scale failure in leishmaniasis‘ alarming’. In TDR News, No. 34, UNDP/World Bank/WHO, Special Programme for Research and Training in Tropical Diseases, UNDP–World Bank–WHO, Geneva, 1990.
3. Das, N., Bachhawat, B. K., Mahato, S. B.& Basu, M. K. (1987). Plant glycosides in a liposomal drug delivery system. Biochemical Journal247, 359–61.
4. Medda, S., Mukherjee, S., Das, N., Naskar, K., Mahato, S. B. & Basu, M. K. (1993). Sugar-coated liposomes: a novel delivery system for increased drug efficacy and reduced drug toxicity. Biotechnology and Applied Biochemistry17, 37–47.
5. Ray, S., Majumder, H. K., Chakraborty, A. K., Mukhopadhyay, S., Gil, R. R. & Cordell, G. A. (1996). Amarogentin, a naturally occurring secoiridoid glycoside, and a newly recognised inhibitor of topoisomerase I from Leishmania donovani. Journal of Natural Products59, 27–9.